As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
Collaborating Institutions
University of Washington
The major goal is to study the role of ILC3 type cells in the mucosal immunity to Mtb infections in macaques. Role: Sub-PI
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
Collaborating Institutions
Emory University
19-050 The major goal is to share the samples collected from the various cohorts of NHPs exhibiting latent as well as reactivation TB. Additionally, we will continue to perform data analysis on previous studies performed during the UH2 portion of the study. Role: MPI
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
Collaborating Institutions
Boston Children's Hospital
The major goal is study if multiple antigen presenting system (MAPS) can effectively boost BCG vaccination responses to protect macaques against lethal Mtb challenge. Role: Sub-PI
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
Collaborating Institutions
Emory University
19-053 The major goal is to develop reagents for and to identify antigen-specific T cell responses in macaques with persistent and cured LTBI. In the first three years of this program project we have infected 12 macaques with ultra low-dose of Mtb to generate LTBI, and developed a model for LTBI clearance by treating half the animals with INH/RIF weekly regimen for 12 weeks. We will now study correlates of clearance in INH/RIF treated and untreated animals using banked PBMCs, stimulated BAL and lung cell samples.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Piergallini, Tucker
Funded by
Douglass Foundation
Increased inflammation affects the immune response to Mycobacterium tuberculosis (M.tb) infection in old and young mice in ways not yet understood. The project objective is to determine the mechanisms in which inflammation influences the response to early M.tb infection in young and old mice. The goal of the project is to determine ways inflammation can be modulated with anti-inflammatory treatment to improveM.tb infection outcome in young and old mice, and to apply this knowledge to benefit tuberculosis disease outcome in elderly persons and persons with increased inflammation.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
Regeneron Pharmaceuticals, Inc.
The goal of this research project is to perform Ebola infected PK/PD qPCR analysis for the efficacy study of mAb therapeutic against EBOV lethal challenge in rhesus macaques.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Varun Dwivedi
Funded by
TxBiomed Forum
We propose a strategy of host derived IL-10 modulation, strictly at the time of vaccination for generating a qualitatively different set of T cells resulting in sustained long-term protection against M.tb infection in mice.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Robert Lanford
Chris Chen
Funded by
Ufovax
This program will test the immunogenicity and efficacy of a novel HIV vaccine.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Marcel Daadi
Funded by
NIH
In this multidisciplinary proposal we will use a nonhuman primate model of Parkinsons disease to study the reversibility of the beneficial effects of physical exercise and its impact on induced pluripotent stem cell (iPSC)-based therapy. We will investigate how exercise and iPSC-based cell therapy reinnervate the striatum and restore movement and gait by recruiting new neural networks as revealed by longitudinal multimodal imaging, behavioral and morphological analysis.